Navigation Links
Valeritas Inc. Selects dLife's New Diabetes Patient Engagement Solution For Valeritas' V-go Disposable Insulin Delivery Device
Date:5/22/2012

WESTPORT, Conn., May 22, 2012 /PRNewswire/ -- Valeritas, the maker of V-Go™ Disposable Insulin Delivery Device, a new, simple disposable device for the delivery of insulin designed especially for adults with type 2 diabetes, has selected dLife to support its state-of-the-art patient engagement program. dLife, the number-one resource and community network for people living with diabetes, and Valeritas have co-developed V-Go Life, a comprehensive diabetes lifestyle management and support program designed to increase engagement of V-Go users. This collaboration is the first of its kind from dLife's recently launched Healthcare Solutions Group, an extension of the dLife media brand that works specifically with health plans, providers, and pharmaceutical and device manufacturers to provide them diabetes engagement, behavior change, and self-management programs.

"The V-Go Life program provides comprehensive support that also addresses the issue of compliance among people living with diabetes," said Kristine Peterson, CEO of Valeritas. "By extending our solution beyond the V-Go device, we can offer people with type 2 diabetes assistance and resources throughout their entire insulin treatment regimen. Our collaboration with dLife is part of Valeritas' strong commitment to improving the lives of people with diabetes."

In this partnership, dLife's Engagement Platform is leveraged to provide users customized content and tools. Resources provided on the website include articles, videos, recipes, polls, quizzes, diet and exercise tips, expert advice, questions of the week, and more that align with and support their personal diabetes management programs, and help support the use and adoption of V-Go. V-Go Life users will be engaged in a 360-degree disease management program that contains a curriculum aimed at helping them adopt and keep engaged with the V-Go product. This will allow them to stay informed and actively engaged in their progress with their personal diabetes self-management.

"We are excited to be working with Valeritas and with the V-Go, a simple product that helps with blood sugar control for adult patients with type 2 diabetes," said Adam Kaufman, PhD, General Manager of dLife Healthcare Solutions. "The V-Go is a device that clearly fits into peoples' diabetes lifestyles and aims to significantly improve self-care; and the V-Go Life solution, built on dLife content and technology, furthers Valeritas' commitment to support the entire diabetes self-management experience."  

The V-Go device makes insulin delivery convenient by delivering a continuous preset basal rate of insulin, as well as on-demand bolus dosing at mealtimes, for one 24-hour period. By eliminating the complicated regimen of injecting throughout the day and minimizing interruptions with daily activities, this method facilitates patient compliance with their therapy and may ultimately lead to improved glucose control. 

Kaufman continued, "The V-Go Life program is customized to the unique demographics and experiences of V-Go patients by drawing upon the diabetes expertise and support that people with diabetes need — something dLife has been offering to diabetes consumers for many years."

V-Go Life will be available at no cost only to patients currently using the V-Go device.  Patients on the V-Go device wishing to enroll in the V-Go Life program should call the 24/7 toll-free Valeritas customer care line at 1-866-881-1209.

For more information about dLife Healthcare Solutions' programs, contact Adam Kaufman at kaufman@dlife.com or 203-221-3442.

About Valeritas, Inc.

Valeritas is a medical technology company committed to the development and commercialization of innovative drug delivery solutions that contribute to clinical and humanistic outcomes for patients, with an initial focus on the treatment of diabetes. The Valeritas medical technologies portfolio is headlined by the h-Patch™ technology. The V-Go Disposable Insulin Delivery Device, designed for the simple delivery of basal-bolus insulin therapy via a preset basal rate and on-demand bolus dosing at mealtimes, is the first use of the h-Patch™ technology.

Headquartered in Bridgewater, NJ, Valeritas operates its R&D and manufacturing in a state-of-the-art facility in Shrewsbury, MA. For more information on Valeritas and the V-Go™ Disposable Insulin Delivery Device, please visit www.valeritas.com and www.go-vgo.com.

About dLife – It's YOUR Diabetes Life!

dLife is the number-one community network and resource for millions of people with diabetes, their caregivers and healthcare providers. dLife engages this growing population in positive and proactive self-care across a variety of media channels. Its award-winning outlets include dLife.com, the leading online diabetes destination, attracting more than one million unique visitors a month, and featuring the widest and deepest variety of original content and resources anywhere; dLifeTV, the only national TV series dedicated to people with diabetes, with over half a million viewers, airing every Sunday on CNBC (7 p.m. ET); popular mobile applications; as well as consumer and professional programs driving proactive diabetes self-management.  dLife has been recognized with numerous media and editorial awards.

dLife Healthcare Solutions applies evidence-based content and technology solutions built specifically for health plans and healthcare providers who want to engage their diabetes populations as consumers of their own  healthcare and owners of their own condition. dLife has demonstrated positive and direct impact on health outcomes via a recently completed randomized trial performed by the Geisinger Healthcare System.

Join dLife on Facebook or follow dLife on Twitter. Watch us on YouTube.

dLife Media Contact:
Emma Ludwin
KNB Communications
203.504.8230 ext. 107
eludwin@knbpr.com

Valeritas Media Contact:
Shannon Coughlin
Twist
212.301.7209
scoughlin@twistmktg.com


'/>"/>
SOURCE dLife Healthcare Solutions
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Valeritas Announces $150 Million Financing
2. Valeritas Receives FDA 510(k) Clearance for the V-Go™ Disposable Insulin Delivery Device for Use with NovoLog®
3. Valeritas Receives FDA 510(k) Clearance for the V-Go™ Disposable Insulin Delivery Device
4. PharmacyGPO Buying Group Selects H. D. Smith as Primary National Distributor
5. Angeion Selects Hendrik Struik for Board of Directors
6. Blue Mountain Hospital Selects Enterprise System from Prognosis HIS
7. FDA Selects CreatiVasc For New Innovation Pathway Program
8. Weill Cornell Medical College Selects Ingenuity® Variant Analysis™ and Ingenuity® iReport™ for Sequencing Core Facility
9. ASLAN Pharmaceuticals Selects PharmaNet/i3 as Strategic Partner For Oncology Development
10. Rubicon Genomics Selects Velesco to Manufacture its TransPLEX® RNA Amplification Kits for Clinical Diagnostic Use
11. Stryker Communications Selects Glowpoint to Enhance IP Video Platform for Operating Rooms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... 2017  GenomeDx Biosciences today announced that six abstracts ... Prostate Cancer Classifier tests will be presented at the ... Congress held March 24 to 28, 2017 in ... is Europe,s largest urological event ... urological field. The abstract titled "Muscle invasive ...
(Date:3/24/2017)... March 23, 2017  Provectus Biopharmaceuticals, Inc. (OTCQB: ... a clinical-stage oncology and dermatology biopharmaceutical company, today ... Commitment Term Sheet (the "Definitive Financing") it entered ... the Company,s stockholders, who are referred to in ... Form 8-K filed with the Securities and Exchange ...
(Date:3/23/2017)... -- Mosaic Life Care, based in St. Joseph, Missouri , has ... of 58 clinics, located in 22 cities, and its flagship St. Joseph Medical Center. ... the delivery of health care to its patients, including the insurance, billing and collections ... ... Mosaic Life Care St. Joseph Medical Center ...
Breaking Medicine Technology:
(Date:3/24/2017)... ... March 24, 2017 , ... “Vintage and Harvest A Cultivation of Christian Love” ... teacher residing in North Carolina with his wife, Anna Marie. He and his wife ... grandchildren. David is also the author of “Shadow and Substance.” , “Love, the agape ...
(Date:3/23/2017)... NC & Seattle, WA (PRWEB) , ... March 23, 2017 , ... ... public health emergency and now estimates that there could be four million Zika-related cases ... growing epidemics to date with numbers of US cases reported per year skyrocketing to ...
(Date:3/23/2017)... , ... March 23, 2017 , ... ... services to their communities, 16 more public health departments have been awarded national ... bring another 4.5 million people into the expanding network of communities across the ...
(Date:3/23/2017)... ... March 23, 2017 , ... The IoT (Internet of Things) ... are making a huge impact on businesses and individual consumers alike. Laboratories can ... will have a value anywhere from $4 trillion to $11 trillion dollars by the ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... services firm serving the families and businesses of the Norwalk and Vermillion ... Northern Ohio Recovery Center (N.O.R.A.) is a nonprofit, community-based substance abuse prevention ...
Breaking Medicine News(10 mins):